Cited by 8,029Heart Failure Treatment and ManagementHeart rate and cardiovascular healthCardiovascular Function and Risk Factors

The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Open access

The SOLVD Investigators*·1991·New England Journal of Medicine

DOI 10.1056/nejm199108013250501

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: Patients with congestive heart failure have a high mortality rate and are also hospitalized frequently. We studied the effect of an angiotensin-converting-enzyme inhibitor, enalapril, on mortality and hospitalization in patients with chronic heart failure and ejection fractions less than or equal to 0.35. METHODS: Patients receiving conventional treatment for heart failure were randomly assigned to receive either placebo (n = 1284) or enalapril (n = 1285) at doses of 2.5 to 20 mg per day in a double-bind trial. Approximately 90 percent of the patients were in New York Heart Association functional classes II and III. The follow-up averaged 41.4 months. RESULTS: There were 510 deaths in the placebo group (39.7 percent), as compared with 452 in the enalapril group (35.2 percent) (reduction in risk, 16 percent; 95 percent confidence interval, 5 to 26 percent; P = 0.0036). Although reductions in mortality were observed in several categories of cardiac deaths, the largest reduction occurred among the deaths attributed to progressive heart failure (251 in the placebo group vs. 209 in the enalapril group; reduction in risk, 22 percent; 95 percent confidence interval, 6 to 35 percent). There was little apparent effect of treatment on deaths classified as due to arrhythmia without pump failure. Fewer patients died or were hospitalized for worsening heart failure (736 in the placebo group and 613 in the enalapril group; risk reduction, 26 percent; 95 percent confidence interval, 18 to 34 percent; P less than 0.0001). CONCLUSIONS: The addition of enalapril to conventional therapy significantly reduced mortality and hospitalizations for heart failure in patients with chronic congestive heart failure and reduced ejection fractions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108013250501

Cites

15 of 15 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1977) · British Journal of Cancer · doi:10.1038/bjc.1977.1 · Cited by 8,285
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A. N., Devereux, R. B., Feigenbaum, H., Gutgesell, H. P., Reichek, N., Sahn, D. J., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,110
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,109
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure
Cohn, J. N., Archibald, D. G., Ziesche, S., Franciosa, J. A., Harston, W. E., Tristani, F. E., Dunkman, W. B., Jacobs, W., Francis, G. S., Flohr, K. H., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198606123142404 · Cited by 2,400
Discrete Sequential Boundaries for Clinical Trials
Lan, K. K. G., & DeMets, D. L. (1983) · Biometrika · doi:10.2307/2336502 · Cited by 2,310
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the Studies of Left Ventricular Dysfunction (SOLVD).
Francis, G. S., Benedict, C. R., Johnstone, D. E., Kirlin, P. C., Nicklas, J. M., Liang, C., Kubo, S. H., Rudin-Toretsky, E., & Yusuf, S. (1990) · Circulation · doi:10.1161/01.cir.82.5.1724 · Cited by 1,386

Show all 15 references

Research works printed but not linked: 1

Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: John Wiley, 1980.

Sorted by citations

Items 301–400 of 1,027

Navigating the Crossroads of Coronary Artery Disease and Heart Failure
Gheorghiade, M., Sopko, G. S., Luca, L. D., Velazquez, E. J., Parker, J. D., Binkley, P. F., Sadowski, Z., Golba, K. S., Prior, D., Rouleau, J. L., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.623199 · Cited by 408
Economics of Chronic Heart Failure
Berry, C., Murdoch, D. R., & McMurray, J. J. V. (2001) · European Journal of Heart Failure · doi:10.1016/s1388-9842(01)00123-4 · Cited by 407
Team Management of Patients With Heart Failure
Grady, K. L., Dracup, K., Kennedy, G. T., Moser, D. K., Piano, M. R., Stevenson, L. W., & Young, J. B. (2000) · Circulation · doi:10.1161/01.cir.102.19.2443 · Cited by 407
Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)
Nussberger, J., Wuerzner, G., Jensen, C., & Brunner, H. R. (2002) · Hypertension · doi:10.1161/hy0102.102293 · Cited by 407
Cost effective management programme for heart failure reduces hospitalisation
Cline, C. M. J., Israelsson, B., Willenheimer, R. B., Broms, K., & Erhardt, L. (1998) · Heart · doi:10.1136/hrt.80.5.442 · Cited by 407
QRS duration and mortality in patients with congestive heart failure
Iuliano, S., Fisher, S. G., Karasik, P., Fletcher, R. D., & Singh, S. N. (2002) · American Heart Journal · doi:10.1067/mhj.2002.122516 · Cited by 405
Role of Diminished Renal Function in Cardiovascular Mortality
Schrier, R. W. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.07.067 · Cited by 402
Heart Failure
Bell, D. S. H. (2003) · Diabetes Care · doi:10.2337/diacare.26.8.2433 · Cited by 402
Impact of diabetes on epidemiology, treatment, and outcomes of patients with heart failure
Dei Cas, A., Khan, S. S., Butler, J., Mentz, R. J., Bonow, R. O., Avogaro, A., Tschoepe, D., Doehner, W., Greene, S. J., Senni, M., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2014.08.004 · Cited by 401
Mortality and Morbidity Reduction With Candesartan in Patients With Chronic Heart Failure and Left Ventricular Systolic Dysfunction
Young, J. B., Dunlap, M. E., Pfeffer, M. A., Probstfield, J. L., Solal, A. C., Dietz, R., Granger, C. B., Hradec, J., Kuch, J., McKelvie, R. S., et al. (2004) · Circulation · doi:10.1161/01.cir.0000146819.43235.a9 · Cited by 401
Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function.
Ridker, P. M., Gaboury, C. L., Conlin, P. R., Seely, E. W., Williams, G. H., & Vaughan, D. E. (1993) · Circulation · doi:10.1161/01.cir.87.6.1969 · Cited by 400
Enhanced Ventilatory Response to Exercise in Patients With Chronic Heart Failure and Preserved Exercise Tolerance
Ponikowski, P. P., Francis, D. P., Piepoli, M. F., Davies, C., Chua, T. P., Davos, C. H., Florea, V. G., Banasiak, W., Poole-Wilson, P. A., Coats, A. J. S., et al. (2001) · Circulation · doi:10.1161/01.cir.103.7.967 · Cited by 398
A Meta-Analysis of the Prognostic Significance of Atrial Fibrillation in Chronic Heart Failure
Mamas, M. A., Caldwell, J. C., Chacko, S., Garratt, C. J., Fath-Ordoubadi, F., & Neyses, L. (2009) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp085 · Cited by 393
Electrical Storm Presages Nonsudden Death
Exner, D. V., Pinski, S. L., Wyse, D. G., Renfroe, E. G., Follmann, D. A., Gold, M. R., Beckman, K. J., Coromilas, J., Lancaster, S. E., & Hallstrom, A. P. (2001) · Circulation · doi:10.1161/01.cir.103.16.2066 · Cited by 393
Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of Cardiology Foundation/American Heart Association/American Association for Thoracic Surgery/Preventive Cardiovascular Nurses Association/Society of Thoracic Surgeons
Qaseem, A., Fihn, S. D., Williams, S., Dallas, P., Owens, D. K., & Shekelle, P. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-10-201211200-00010 · Cited by 391
Comparison of vasopeptidase inhibitor, omapatrilat, and lisinopril on exercise tolerance and morbidity in patients with heart failure: IMPRESS randomised trial
Rouleau, J. L., Pfeffer, M. A., Stewart, D. J., Isaac, D., Sestier, F., Kerut, E. K., Porter, C., Proulx, G., Qian, C., & Block, A. J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02602-7 · Cited by 391
Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts.
Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K., Chang, K., & Baker, K. M. (1993) · Circulation Research · doi:10.1161/01.res.72.6.1245 · Cited by 391
Prediction of risk for first age-related cardiovascular events in an elderly population: the incremental value of echocardiography
Tsang, T. S. M., Barnes, M. E., Gersh, B. J., Takemoto, Y., Rosales, A. G., Bailey, K. R., & Seward, J. B. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00943-4 · Cited by 390
Prognostic Implications of Changes in N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Heart Failure
Zile, M. R., Claggett, B. L., PRESCOTT, M. F., McMurray, J. J. V., Packer, M., Rouleau, J. L., Swedberg, K. B., Desai, A. S., Gong, J., Shi, V. C., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.09.931 · Cited by 387
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
Kjekshus, J., Pedersen, T. R., Olsson, A. G., Færgeman, O., & Pyörälä, K. (1997) · Journal of Cardiac Failure · doi:10.1016/s1071-9164(97)90022-1 · Cited by 386
Congestive Heart Failure in the Community
Senni, M., Tribouilloy, C. M., Rodeheffer, R. J., Jacobsen, S. J., Evans, J. M., Bailey, K. R., & Redfield, M. M. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.1.29 · Cited by 384
Tissue Engineering and Regenerative Medicine: Achievements, Future, and Sustainability in Asia
Han, F., Wang, J., Ding, L., Hu, Y., Li, W., Yuan, Z., Guo, Q., Zhu, C., Yu, L., Wang, H., et al. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00083 · Cited by 382
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: a follow-up study
Jong, P., Yusuf, S., Rousseau, M. F., Ahn, S. A., & Bangdiwala, S. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13501-5 · Cited by 380
Diuretics and Risk of Arrhythmic Death in Patients With Left Ventricular Dysfunction
Cooper, H. A., Dries, D. L., DAVIS, C. E., Shen, Y. L., & DOMANSKI, M. J. (1999) · Circulation · doi:10.1161/01.cir.100.12.1311 · Cited by 380
Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model
Zhang, Y., Popović, Z., Bibevski, S., Fakhry, I., Sica, D. A., Wagoner, D. R. V., & Mazgalev, T. N. (2009) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.873968 · Cited by 377
Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction
Maisel, A. S., Koon, J., Krishnaswamy, P., Kazenegra, R., Clopton, P., Gardetto, N. J., Morrisey, R., Garcia, A., Chiu, A., & DeMaria, A. N. (2001) · American Heart Journal · doi:10.1067/mhj.2001.113215 · Cited by 377
Clinical Determinants of Mortality in Patients With Angiographically Diagnosed Ischemic or Nonischemic Cardiomyopathy
Bart, B. A., Shaw, L. K., McCants, C. B., Fortin, D. F., Lee, K. L., Califf, R. M., & O’Connor, C. M. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00235-0 · Cited by 375
The REMATCH trial: rationale, design, and end points
Rose, E. A., Moskowitz, A. J., Packer, M., Sollano, J. A., Williams, D. L., Tierney, A. R., Heitjan, D. F., Meier, P., Ascheim, D. D., Levitan, R. G., et al. (1999) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(99)00042-9 · Cited by 375
Diuretic resistance predicts mortality in patients with advanced heart failure
Neuberg, G. W., Miller, A. B., O’Connor, C., Belkin, R. N., Carson, P. E., Cropp, A. B., Frid, D. J., Nye, R., Pressler, M. L., WERTHEIMER, J. H., et al. (2002) · American Heart Journal · doi:10.1067/mhj.2002.123144 · Cited by 374
2023 ESC Guidelines for the management of acute coronary syndromes
Byrne, R. A., Rosselló, X., Coughlan, J. J., Barbato, E., Berry, C., Chieffo, A., Claeys, M. J., Dan, G., Dweck, M. R., Galbraith, M., et al. (2023) · European Heart Journal Acute Cardiovascular Care · doi:10.1093/ehjacc/zuad107 · Cited by 373
Angiotensin II and Aldosterone Regulate Gene Transcription Via Functional Mineralocortocoid Receptors in Human Coronary Artery Smooth Muscle Cells
Jaffe, I. Z., & Mendelsohn, M. E. (2005) · Circulation Research · doi:10.1161/01.res.0000159937.05502.d1 · Cited by 372
Vasoprotection by nitric oxide: mechanisms and therapeutic potential
Gewaltig, M. T. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00327-9 · Cited by 371
Renin–angiotensin–aldosterone system blockade for cardiovascular diseases: current status
Terry, K. W., Kam, K. K., Yan, B. P., & Lam, Y. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00750.x · Cited by 370
Racial Differences in the Outcome of Left Ventricular Dysfunction
Dries, D. L., Exner, D. V., Gersh, B. J., Cooper, H. A., Carson, P. E., & DOMANSKI, M. J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902253400804 · Cited by 368
Effects of Carvedilol on Heart Failure with Preserved Ejection Fraction: the Japanese Diastolic Heart Failure Study (J-DHF)
Yamamoto, K., Origasa, H., & Hori, M. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs141 · Cited by 366
The EPHESUS Trial: Eplerenone in Patients with Heart Failure Due to Systolic Dysfunction Complicating Acute Myocardial Infarction
Pitt, B., Williams, G. H., Remme, W. J., Martínez, F., Lopez-Sendon, J. L., Zannad, F. M., Neaton, J. D., Roniker, B., Hurley, S., Burns, D. M., et al. (2001) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1011119003788 · Cited by 364
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy
Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., & Wilcox, C. S. (2001) · Circulation · doi:10.1161/hc4101.096153 · Cited by 363
The treatment of heart failure: The Task Force of the Working Group on Heart Failure of the European Society of Cardiology
Remme, W. J., Cleland, J. G. F., Dargie, H. J., Erdmann, E., Ferrari, R., Kjekshus, J., Michel Komajda, N., Poole-Wilson, P. A., Riegger, G. A. J., Soler‐Soler, J., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015339 · Cited by 362
BNP Consensus Panel 2004: A Clinical Approach for the Diagnostic, Prognostic, Screening, Treatment Monitoring, and Therapeutic Roles of Natriuretic Peptides in Cardiovascular Diseases
Silver, M. A., Maisel, A. S., Yancy, C. W., McCullough, P. A., Burnett, J. C. J., Francis, G. S., Mehra, M. R., Peacock, W. F., Fonarow, G. C., Gibler, W. B., et al. (2004) · Congestive Heart Failure · doi:10.1111/j.1527-5299.2004.03271.x · Cited by 361
Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure
Floras, J. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90466-e · Cited by 360
Natural history and patterns of current practice in heart failure
Bourassa, M. G., Gurné, O., Bangdiwala, S. I., Ghali, J. K., Young, J. B., Rousseau, M. F., Johnstone, D. E., & Yusuf, S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90456-b · Cited by 360
Risk Related to Pre–Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial
Kristensen, S. L., Preiss, D., Jhund, P. S., Squire, I., Cardoso, J. S., Merkely, B., Martinez, F., Starling, R. C., Desai, A. S., Lefkowitz, M. P., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002560 · Cited by 359
Obstructive Sleep Apnea and Heart Failure
Kasai, T., & Bradley, T. D. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.08.627 · Cited by 359
Chronic Heart Failure in Congenital Heart Disease
Stout, K., Broberg, C. S., Book, W., Cecchin, F., Chen, J. M., Dimopoulos, K., Everitt, M. D., Gatzoulis, M. Α., Harris, L., Hsu, D. T., et al. (2016) · Circulation · doi:10.1161/cir.0000000000000352 · Cited by 357
Effect of the Calcium Antagonist Felodipine as Supplementary Vasodilator Therapy in Patients With Chronic Heart Failure Treated With Enalapril
Cohn, J. N., Ziesche, S., Smith, R. F., Anand, I. S., Dunkman, W. B., Loeb, H. S., Cintron, G. B., Boden, W. E., Baruch, L., Rochin, P., et al. (1997) · Circulation · doi:10.1161/01.cir.96.3.856 · Cited by 357
Effects of valsartan on morbidity and mortality in patients with heart failure not receiving angiotensin-converting enzyme inhibitors
Maggioni, A. P., Anand, I., Gottlieb, S. O., Latini, R., Tognoni, G., & Cohn, J. N. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02304-5 · Cited by 356
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials
Bangalore, S., Kumar, S., Kjeldsen, S. E., Makani, H. J., Grossman, E., Wetterslev, J., Gupta, A. K., Sever, P., Gluud, C. N., & Messerli, F. H. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70260-6 · Cited by 356
Diabetic cardiomyopathy: mechanisms, diagnosis and treatment
Hayat, S. A., Patel, B., Khattar, R. S., & Malik, R. A. (2004) · Clinical Science · doi:10.1042/cs20040057 · Cited by 353
Baseline Quality of Life as a Predictor of Mortality and Hospitalization in 5,025 Patients With Congestive Heart Failure
Konstam, V., Salem, D. N., Pouleur, H. G., Kostis, J. B., Gorkin, L., Shumaker, S. A., Mottard, I., Woods, P., Konstam, M. A., & Yusuf, S. (1996) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00463-8 · Cited by 352
Long-term effects of darusentan on left-ventricular remodelling and clinical outcomes in the Endothelin A Receptor Antagonist Trial in Heart Failure (EARTH): randomised, double-blind, placebo-controlled trial
Anand, I. S., McMurray, J. J. V., Cohn, J. N., Konstam, M. A., Notter, T., Quitzau, K., Ruschitzka, F. T., & Lüscher, T. F. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16723-8 · Cited by 352
Heart Failure in Cardiomyopathies: A Position Paper from the Heart Failure Association of the European Society of Cardiology
Seferović, P. M., Polovina, M., Bauersachs, J., Arad, M., Ben Gal, T., Lund, L. H., Felix, S. B., Arbustini, E., Caforio, A. L. P., Farmakis, D., et al. (2019) · European Journal of Heart Failure · doi:10.1002/ejhf.1461 · Cited by 346
Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design
Fonarow, G. C., Abraham, W. T., Albert, N. M., Gattis, W. A., Gheorghiade, M., Greenberg, B., O’Connor, C., Yancy, C. W., & Young, J. B. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.004 · Cited by 346
Perindopril preventive treatment on mortality in Duchenne muscular dystrophy: 10 years' follow-up
Duboc, D., Meune, C., Pierre, B., Wahbi, K., Eymard, B., Toutain, A., Berard, C., Vaksmann, G., Weber, S., & Bécane, H. M. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.05.014 · Cited by 346
Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction
Ho, J. E., Lyass, A., Lee, D. S., Vasan, R. S., Kannel, W. B., Larson, M. G., & Levy, D. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.972828 · Cited by 343
Treatment of Congestive Heart Failure and Cheyne-Stokes Respiration during Sleep by Continuous Positive Airway Pressure
Naughton, M. T., Liu, P. P., Bernard, D., Goldstein, R. S., & Bradley, T. D. (1995) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.151.1.7812579 · Cited by 343
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
Stelken, A. M., Younis, L. T., Jennison, S. H., Miller, D. D., Miller, L. W., Shaw, L. J., Kargl, D., & CHAITMAN, B. R. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00464-5 · Cited by 342
A Comprehensive Management System for Heart Failure Improves Clinical Outcomes and Reduces Medical Resource Utilization
West, J. A., Miller, N. H., Parker, K. M., Senneca, D., Ghandour, G., Clark, M., Greenwald, G., Heller, R. S., Fowler, M. B., & DeBusk, R. F. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(96)00676-5 · Cited by 341
Diuretic use, progressive heart failure, and death in patients in the studies of left ventricular dysfunction (SOLVD)
DOMANSKI, M. J., Norman, J. E., Pitt, B., Haigney, M. C., Hanlon, S. U., & Peyster, E. G. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00765-4 · Cited by 339
2014 ESC/EACTS Guidelines on myocardial revascularization
Windecker, S., Kolh, P. H., Alfonso, F., Collet, J., Cremer, J., Falk, V., Filippatos, G. S., Hamm, C. W., Head, S. J., Jüni, P., et al. (2015) · EuroIntervention · doi:10.4244/eijy14m09_01 · Cited by 339
The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure.
Liggett, S. B., Wagoner, L. E., Craft, L., Hornung, R., Hoit, B. D., McIntosh, T., & Walsh, R. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci4059 · Cited by 339
Immunoglobulin Adsorption in Patients With Idiopathic Dilated Cardiomyopathy
Müller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., Nissen, E., Kunze, R., & Hetzer, R. (2000) · Circulation · doi:10.1161/01.cir.101.4.385 · Cited by 337
Acute Coronary Findings at Autopsy in Heart Failure Patients With Sudden Death
Uretsky, B. F., Thygesen, K. A., Armstrong, P. W., Cleland, J. G. F., Horowitz, J. D., Massie, B. M., Packer, M., Poole-Wilson, P. A., & Rydén, L. (2000) · Circulation · doi:10.1161/01.cir.102.6.611 · Cited by 336
Biomarker-guided therapy in chronic heart failure: A meta-analysis of randomized controlled trials
Felker, G. M., Hasselblad, V., Hernandez, A. F., & O’Connor, C. M. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.06.018 · Cited by 336
Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure
Masoudi, F. A., Havranek, E. P., Wolfe, P., Gross, C. P., Rathore, S. S., Steiner, J. F., Ordin, D. L., & Krumholz, H. M. (2003) · American Heart Journal · doi:10.1016/s0002-8703(03)00189-3 · Cited by 335
Mode of Death in Patients With Heart Failure and a Preserved Ejection Fraction
Zile, M. R., Gaasch, W. H., Anand, I. S., Haass, M., Little, W. C., Miller, A. B., Lopez-Sendon, J. L., Teerlink, J. R., White, M., McMurray, J. J. V., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.909614 · Cited by 334
Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure
Lucas, C., Johnson, W. S., Hamilton, M. A., Fonarow, G. C., Woo, M. A., Flavell, C. M., Creaser, J. A., & Stevenson, L. W. (2000) · American Heart Journal · doi:10.1067/mhj.2000.110933 · Cited by 333
Prevention of cardiovascular events in end-stage renal disease: Results of a randomized trial of fosinopril and implications for future studies
Zannad, F. M., Kessler, M., Lehert, P., Grünfeld, J., Thuilliez, C., Leizorovicz, A., Lechat, P. P., & for the Fosidial Investigators (2006) · Kidney International · doi:10.1038/sj.ki.5001657 · Cited by 333
Acute Precipitants of Congestive Heart Failure Exacerbations
Tsuyuki, R. T., McKelvie, R. S., Arnold, J. M. O., Avezum, Á., Barretto, A. C. P., Carvalho, A. C., Isaac, D., Kitching, A. D., Piegas, L. S., Teo, K. K., et al. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.19.2337 · Cited by 333
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
Law, M. G., Wald, N., & Morris, J. K. (2003) · Health Technology Assessment · doi:10.3310/hta7310 · Cited by 332
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Gurley, S. B., Allred, A. J., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T., Donoghue, M., Breitbart, R. E., Acton, S. L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci16980 · Cited by 331
Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular diseaseThe Task Force on ACE-inhibitors of the European Society of Cardiology
Lopez-Sendon, J. L., Swedberg, K. B., McMurray, J. J. V., Tamargo, J. L., Maggioni, A. P., Dargie, H., Tendera, M., Waagstein, F., Kjekshus, J., Lechat, P. P., et al. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.06.003 · Cited by 331
Acute Hemodynamic Improvement by Thermal Vasodilation in Congestive Heart Failure
Tei, C., Horikiri, Y., Park, J.-C., Jeong, J., Chang, K.-S., Toyama, Y., & Tanaka, N. (1995) · Circulation · doi:10.1161/01.cir.91.10.2582 · Cited by 329
Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure
Gheorghiade, M., Böhm, M., Greene, S. J., Fonarow, G. C., Lewis, E. F., Zannad, F. M., Solomon, S. D., Baschiera, F., Botha, J., Hua, T. A., et al. (2013) · JAMA · doi:10.1001/jama.2013.1954 · Cited by 328
The Management of Chronic Heart Failure
Cohn, J. N. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608153350707 · Cited by 328
High Risk of Symptomatic Cardiac Events in Childhood Cancer Survivors
van der Pal, H. J. H., van Dalen, E. C., van Delden, E., van Dijk, I. W. E. M., Kok, W. E. M., Geskus, R. B., Sieswerda, E., Oldenburger, F. R., Koning, C. C. E., van Leeuwen, F. E., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.4730 · Cited by 326
Consensus statement: palliative and supportive care in advanced heart failure
Goodlin, S. J., Hauptman, P. J., Arnold, R. M., Grady, K. L., Hershberger, R. E., Kutner, J. S., Masoudi, F. A., Spertus, J. A., Dracup, K., Cleary, J. F., et al. (2004) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2003.09.006 · Cited by 324
Screening Adult Survivors of Childhood Cancer for Cardiomyopathy: Comparison of Echocardiography and Cardiac Magnetic Resonance Imaging
Armstrong, G. T., Plana, J. C., Zhang, N., Srivastava, D. K., Green, D. M., Ness, K. K., Donovan, F., Metzger, M. L., Arévalo, A., Durand, J., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.3584 · Cited by 324
Improved outcomes in peripartum cardiomyopathy with contemporary
Amos, A., Jaber, W. A., & Russell, S. D. (2006) · American Heart Journal · doi:10.1016/j.ahj.2006.02.008 · Cited by 324
B-Type Natriuretic Peptide–Guided Heart Failure Therapy
Porapakkham, P. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.35 · Cited by 323
Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats.
Takemoto, M., Egashira, K., Usui, M., Numaguchi, K., Tomita, H., Tsutsui, H., Shimokawa, H., Sueishi, K., & Takeshita, A. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119156 · Cited by 322
Diagnostic and Therapeutic Challenges in Patients With Coexistent Chronic Obstructive Pulmonary Disease and Chronic Heart Failure
Jemtel, T. H. L., Padeletti, M., & Jelić, S. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.08.046 · Cited by 321
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M. L., Konstam, M. A., MANCINI, D. M., Michl, K., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.023 · Cited by 319
Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators.
Konstam, M. A., Kronenberg, M. W., Rousseau, M. F., Udelson, J. E., Melin, J., Stewart, D., Dolan, N., Edens, T. R., Ahn, S., & Kinan, D. (1993) · Circulation · doi:10.1161/01.cir.88.5.2277 · Cited by 316
Serial Echocardiographic-Doppler Assessment of Left Ventricular Geometry and Function in Rats With Pressure-Overload Hypertrophy
Litwin, S. E., Katz, S. E., Weinberg, E. O., Lorell, B. H., Aurigemma, G. P., & Douglas, P. S. (1995) · Circulation · doi:10.1161/01.cir.91.10.2642 · Cited by 316
Heart failure in the general population of men - morbidity, risk factors and prognosis
Wilhelmsen, L., Rosengren, A., Eriksson, H., & Lappas, G. (2001) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2001.00801.x · Cited by 315
Chagas' Heart Disease
Rassi, A., Rassi, A., & Little, W. C. (2000) · Clinical Cardiology · doi:10.1002/clc.4960231205 · Cited by 315
Assessment of Conventional Cardiovascular Risk Factors and Multiple Biomarkers for the Prediction of Incident Heart Failure and Atrial Fibrillation
Smith, J. G., Newton‐Cheh, C., Almgren, P., Struck, J., Morgenthaler, N. G., Bergmann, A., Platonov, P. G., Hedblad, B., Engström, G., Wang, T. J., et al. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.05.049 · Cited by 314
Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction
Lerman, A., Gibbons, R. J., Rodeheffer, R. J., Bailey, K. R., McKinley, L. J., Heublein, D. M., & Burnett, J. C. J. (1993) · The Lancet · doi:10.1016/0140-6736(93)93125-k · Cited by 313
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment
Volpe, M., Carnovali, M., & Mastromarino, V. (2015) · Clinical Science · doi:10.1042/cs20150469 · Cited by 312
Increased Angiotensin-(1-7)–Forming Activity in Failing Human Heart Ventricles
Zisman, L. S., Keller, R. S., Weaver, B. A., Lin, Q., Speth, R. C., Bristow, M. R., & Canver, C. C. (2003) · Circulation · doi:10.1161/01.cir.0000094734.67990.99 · Cited by 309
Transcatheter Self‐Powered Ultrasensitive Endocardial Pressure Sensor
Liu, Z., Ma, Y., Ouyang, H., Shi, B., Li, N., Jiang, D., Xie, F., Qu, D., Zou, Y., Huang, Y., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201807560 · Cited by 308
Long-Term Enalapril Therapy for Left Ventricular Dysfunction in Doxorubicin-Treated Survivors of Childhood Cancer
Lipshultz, S. E., Lipsitz, S. R., Sallan, S. E., Simbre, V. C., Shaikh, S., Mone, S. M., Gelber, R. D., & Colan, S. D. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.12.102 · Cited by 308
107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th–9th June 2002, Naarden, the Netherlands
Bushby, K., Muntoni, F., & Bourke, J. P. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00213-4 · Cited by 306
Angiotensin II Signal Transduction in Vascular Smooth Muscle
Berk, B. C., & Corson, M. A. (1997) · Circulation Research · doi:10.1161/01.res.80.5.607 · Cited by 306
Anthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
Barry, E. V., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1039 · Cited by 305
Hallmarks of cardiovascular ageing
Abdellatif, M., Rainer, P. P., Sedej, S., & Kroemer, G. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00881-3 · Cited by 305
Fluvastatin, a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction
Hayashidani, S., Tsutsui, H., Shiomi, T., Suematsu, N., Kinugawa, S., Ide, T., Wen, J., & Takeshita, A. (2002) · Circulation · doi:10.1161/hc0702.104164 · Cited by 305
Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: A randomized, double-blind, placebo-controlled study
Eichhorn, E. J., Heesch, C. M., Barnett, J. H., Alvarez, L. G., Fass, S. M., Grayburn, P. A., Hatfield, B. A., Marcoux, L., & Malloy, C. R. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90114-7 · Cited by 305
Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
Gislason, G., Rasmussen, J. N., Abildstrom, S. Z., Gadsbøll, N., Buch, P., Friberg, J., Rasmussen, S., Køber, L., Stender, S., Madsen, M., et al. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi705 · Cited by 304

Authors: The SOLVD Investigators*
Corresponding author: The SOLVD Investigators*
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08
Volume: 325
Issue: 5
Pages: 293-302
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108013250501
OpenAlex: W2585382523
Cited by: 8,029
References: 15
Citations by year: 2026: 78 · 2025: 89 · 2024: 117 · 2023: 152 · 2022: 174 · 2021: 167 · 2020: 182 · 2019: 174 · 2018: 174 · 2017: 187 · 2016: 211 · 2015: 208 · 2014: 165 · 2013: 168 · 2012: 231
FWCI: 170.62
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Keywords: enalapril, ACE inhibitors, congestive heart failure, reduced left ventricular ejection fraction, mortality, hospitalization, heart failure progression, cardiac arrhythmias, NYHA functional class
MeSH terms: Blood Pressure, Cause of Death, Chronic Disease, Double-Blind Method, Electrolytes, Enalapril, Female, Follow-Up Studies, Heart Failure, Hospitalization, Humans, Kidney, Male, Middle Aged, Patient Compliance, Stroke Volume, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks